| Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity R Vogels, D Zuijdgeest, R van Rijnsoever, E Hartkoorn, I Damen, ... Journal of virology 77 (15), 8263-8271, 2003 | 564 | 2003 |
| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 547 | 2018 |
| Pericellular proteases in angiogenesis and vasculogenesis VWM van Hinsbergh, MA Engelse, PHA Quax Arteriosclerosis, thrombosis, and vascular biology 26 (4), 716-728, 2006 | 519 | 2006 |
| Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction L Timmers, JPG Sluijter, JK van Keulen, IE Hoefer, MGJ Nederhoff, ... Circulation research 102 (2), 257-264, 2008 | 425 | 2008 |
| Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind … YH Kusumanto, V Van Weel, NH Mulder, AJ Smit, J Van Den Dungen, ... Human gene therapy 17 (6), 683-691, 2006 | 420 | 2006 |
| Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells ADV Oorschot, DF Fischer, JM Grimbergen, B Klein, SM Zhuang, ... Proceedings of the National Academy of Sciences 94 (11), 5843-5847, 1997 | 407 | 1997 |
| Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP‐stimulated bone formation RL Van Bezooijen, JP Svensson, D Eefting, A Visser, G van der Horst, ... Journal of Bone and Mineral Research 22 (1), 19-28, 2007 | 393 | 2007 |
| Restenosis after PCI. Part 1: pathophysiology and risk factors JW Jukema, JJW Verschuren, TAN Ahmed, PHA Quax Nature Reviews Cardiology 9 (1), 53-62, 2012 | 362 | 2012 |
| In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions A Vink, AH Schoneveld, JJ van der Meer, BJ van Middelaar, JPG Sluijter, ... Circulation 106 (15), 1985-1990, 2002 | 339 | 2002 |
| Antagomir‐mediated silencing of endothelial cell specific microRNA‐126 impairs ischemia‐induced angiogenesis C van Solingen, L Seghers, R Bijkerk, JMGJ Duijs, MK Roeten, ... Journal of cellular and molecular medicine 13 (8a), 1577-1585, 2009 | 331 | 2009 |
| Vein graft failure: from pathophysiology to clinical outcomes MR De Vries, KH Simons, JW Jukema, J Braun, PHA Quax Nature Reviews Cardiology 13 (8), 451-470, 2016 | 282 | 2016 |
| Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease MJE Havenga, AAC Lemckert, O Ophorst, M Van Meijer, WTV Germeraad, ... Journal of virology 76 (9), 4612-4620, 2002 | 282 | 2002 |
| Toll-like receptor 4 is involved in outward arterial remodeling SCG Hollestelle, MR De Vries, JK Van Keulen, AH Schoneveld, A Vink, ... Circulation 109 (3), 393-398, 2004 | 278 | 2004 |
| Drug-eluting stents: results, promises and problems BL Van der Hoeven, NMM Pires, HM Warda, PV Oemrawsingh, ... International journal of cardiology 99 (1), 9-17, 2005 | 263 | 2005 |
| Epigenetics in atherosclerosis and inflammation RJ Wierda, SB Geutskens, JW Jukema, PHA Quax, PJ van den Elsen Journal of cellular and molecular medicine 14 (6a), 1225-1240, 2010 | 222 | 2010 |
| Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix A Collen, R Hanemaaijer, F Lupu, PHA Quax, N van Lent, J Grimbergen, ... Blood, The Journal of the American Society of Hematology 101 (5), 1810-1817, 2003 | 217 | 2003 |
| Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease D Pons, FR de Vries, PJ van den Elsen, BT Heijmans, PHA Quax, ... European heart journal 30 (3), 266-277, 2009 | 208 | 2009 |
| Natural Killer Cells and CD4+ T-Cells Modulate Collateral Artery Development V Van Weel, REM Toes, L Seghers, MML Deckers, MR De Vries, ... Arteriosclerosis, thrombosis, and vascular biology 27 (11), 2310-2318, 2007 | 195 | 2007 |
| Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. TJ de Vries, PH Quax, M Denijn, KN Verrijp, JH Verheijen, HW Verspaget, ... The American journal of pathology 144 (1), 70, 1994 | 189 | 1994 |
| Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction F Arslan, MB Smeets, PW Riem Vis, JC Karper, PH Quax, LG Bongartz, ... Circulation research 108 (5), 582-592, 2011 | 187 | 2011 |
Margreet de Vriesassistent professor LUMCDirección de correo verificada de lumc.nl
